Non-clinical safety assessment of NES100 to support analgesia indication. POP: 09/17/2020 to 03/16/2021.
Ended Awarded Last action
- Contract number
- 75N95020F00002
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $464,908
Award facts
- Opportunity
-
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Pre-Solicitation · N01TR17200220 · Posted Apr 7, 2020
- Contract value 100% obligated
- $464,908.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $464,908 |
About this award
This is a cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $464,908.00 contract is for non-clinical safety assessment of the drug candidate NES100 to support its development for an analgesia (pain relief) indication. The period of performance is from September 17, 2020 to March 16, 2021. This delivery order is part of a larger NCATS indefinite delivery, indefinite quantity (IDIQ) contract vehicle for contract research organization (CRO) support for in vitro and in vivo toxicology studies. Sri International has previously performed a variety of research and development services for government agencies like the Department of Defense, NASA, and NIH through prime contracts and subcontracts.
Quick answers
Who was awarded contract 75N95020F00002?
75N95020F00002 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on September 17, 2020.
How much is contract 75N95020F00002 worth?
The government has obligated $464,908 on 75N95020F00002.
Which agency awarded contract 75N95020F00002?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020F00002, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95020F00002 an order under another contract?
Yes. 75N95020F00002 is a delivery order under HHSN271201700014I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract 75N95020F00002 competed?
The extent of competition for 75N95020F00002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award